Adjustable TransObturator Male System (ATOMS) After Radiotherapy: Is Timing Everything? A Single‐Center Experience
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Marc Kidess und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Suburethral Slings, Prostatic Neoplasms, Prostatectomy, Urinary Incontinence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
Incontinence after prostate treatment (IPT) following radical prostatectomy and/or radiotherapy for prostate cancer significantly impacts quality of life. While the Adjustable Transobturator Male System (ATOMS) is a promising surgical option for IPT, data on outcomes in patients undergoing ATOMS implantation with prior radiotherapy are limited. This study evaluates the influence of prior radiotherapy—and its timing—on outcomes following ATOMS implantation. Materials and Methods This retrospective single‐center study included 131 men treated with ATOMS for IPT between November 2018 and May 2024. Patients were stratified by history of having received radiotherapy and also by timing of radiotherapy ( ≤ 24 vs. > 24 months) before ATOMS implantation. Pre‐, peri‐, and postoperative variables were recorded. Cross‐sectional follow‐up was conducted in November 2024 using clinical questionnaires, 24‐h‐pad‐tests, and validated instruments (PGI, ICIQ‐UI). Statistical analysis included t ‐tests, Mann–Whitney U tests, Chi‐square tests, Kaplan–Meier curves, and Cox regression.
Results
Forty seven patients (35.9%) received radiotherapy before ATOMS implantation. These patients had higher tumor stages and Gleason scores. Postoperatively, radiated patients demonstrated lower complete continence rates (21% vs. 51%, p = 0.020) and higher median pad use (2.5 vs. 1, p < 0.01). Furthermore, they experienced higher rates of acute urinary retention (8.5% vs. 0%, p = 0.029) and explantation (21% vs. 6%, p = 0.018). No significant differences in satisfaction, long‐term continence, or outcomes were found based on the timing of radiotherapy.
Conclusion
ATOMS is an adequate treatment for IPT regardless of radiotherapy history or timing before its implantation. Although significant differences in immediate continence rates were observed (21% vs. 51%), long‐term continence rates were comparable. Therefore, ATOMS seems to be a viable option in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Hospital of Munich, Munich, Germany.
- Urologie Maximilianstrasse, Munich, Germany.
ORCID-Profile: Marc Kidess, Benedikt Ebner, Michael Chaloupka, Yannic Volz
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kidess, M., Lederer, E., Pyrgidis, N., Georgieva, T., Hermans, J., Stadelmeier, L., Hoffmann, M., Ebner, B., Keller, P., Chaloupka, M., Marcon, J., Weinhold, P., Bauer, R., Stief, C. G., & Volz, Y. (2025). Adjustable TransObturator Male System (ATOMS) After Radiotherapy: Is Timing Everything? A Single‐Center Experience. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70158
Vancouver
Kidess M, Lederer E, Pyrgidis N, Georgieva T, Hermans J, Stadelmeier L, et al. Adjustable TransObturator Male System (ATOMS) After Radiotherapy: Is Timing Everything? A Single‐Center Experience. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70158
BibTeX
@article{Kidess2025,
author = {Kidess, Marc and Lederer, Elisa and Pyrgidis, Nikolaos and Georgieva, Troya and Hermans, Julian and Stadelmeier, Leo and Hoffmann, Marina and Ebner, Benedikt and Keller, Patrick and Chaloupka, Michael and Marcon, Julian and Weinhold, Philipp and Bauer, Ricarda and Stief, Christian G and Volz, Yannic},
title = {Adjustable TransObturator Male System (ATOMS) After Radiotherapy: Is Timing Everything? A Single‐Center Experience},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.70158}
}
EUVIMED